Expression Therapeutics

Expression Therapeutics (ET) is a privately owned biotechnology company founded in 2005 with its headquarters located in Atlanta, Georgia. The company’s product pipeline includes a comprehensive suite of products aimed at improving and expanding hemophilia care globally. ET's patented and patent-pending core technology involves "expression" elements designed to produce more effective and economical treatments for hemophilia. The company’s expression-engineered cell, gene, and protein products are expected to revolutionize the global treatment of hemophilia.